YC W16Acquired
Luminist Labs
Diagnostic platform for early detection of liver disease
About
Luminist developed a non-invasive diagnostic test for the early detection and staging of liver fibrosis and non-alcoholic steatohepatitis (NASH). Luminist was acquired in 2020 by DiscernDx.
Founder
Family Office Investors
Altss tracks family office allocations to YC-backed companies. Request access to see which family offices have invested in Luminist Labs.
See family office activityIndustry & Focus
HealthcareDiagnosticsMedical DevicesGenomics